tumor

The outcome changed when researchers stopped fibroblasts inside the tumor from producing C3.

From Science Daily ● Aug. 8, 2026

The FDA reviewers said they couldn’t tell whether tumor responses came from RP1 itself or from a drug manufactured by Bristol-Myers Squibb it was paired with.

From The Wall Street Journal ● Jul. 30, 2026

RP1 is engineered to kill tumor cells directly and then trigger a broader immune response.

From The Wall Street Journal ● Jul. 30, 2026

What we do know is that medical experts warn of extreme risk in their use—there’s some suspicion that at least one of the peptides might accelerate tumor growth.

From Slate ● Jul. 29, 2026

Kevin was placed in a Children’s Hospital to undergo a brain biopsy for a misdiagnosed tumor.

From "The Freedom Writers Diary" by The Freedom Writers

This approach allowed immunotherapy to work against tumors that had previously resisted treatment.

From Science Daily ● Aug. 8, 2026

There are even early suggestions that vitamin C may help the immune system recognize and attack tumors, though this remains speculative.

From Science Daily ● Aug. 7, 2026

Replimune’s drug, marketed as Tudriqev, is a genetically modified virus that doctors inject directly into tumors, where it is designed to kill cancer cells and trigger an immune response against tumors elsewhere in the body.

From The Wall Street Journal ● Aug. 6, 2026

The same biological machinery that helps tumors grow rapidly may therefore make their DNA increasingly unstable, potentially enabling cancers to change, adapt, and become more aggressive.

From Science Daily ● Aug. 2, 2026

That was an indication that patients might survive bombardments that killed their tumors.

From "Big Science" by Michael Hiltzik